Advagene Biopharma Co., Ltd. (6709.TWO)
TWD 18.45
(2.5%)
TWD 18.45
(2.5%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -92.11 Million TWD | 22.19% |
| 2022 | -118.37 Million TWD | -27.72% |
| 2021 | -92.68 Million TWD | -32.1% |
| 2020 | -70.16 Million TWD | 23.42% |
| 2019 | -91.61 Million TWD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -15.7 Million TWD | 30.94% |
| 2024 Q2 | -15.7 Million TWD | 0.0% |
| 2023 FY | -92.11 Million TWD | 22.19% |
| 2023 Q4 | -22.74 Million TWD | 0.0% |
| 2023 Q3 | -22.74 Million TWD | 2.46% |
| 2023 Q2 | -23.31 Million TWD | 0.0% |
| 2023 Q1 | -23.31 Million TWD | 25.27% |
| 2022 Q3 | -31.2 Million TWD | 0.0% |
| 2022 FY | -118.37 Million TWD | -27.72% |
| 2022 Q4 | -31.2 Million TWD | 0.0% |
| 2021 FY | -92.68 Million TWD | -32.1% |
| 2020 FY | -70.16 Million TWD | 23.42% |
| 2019 FY | -91.61 Million TWD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 251.01 Million TWD | 136.695% |
| Level Biotechnology Inc. | 62.9 Million TWD | 246.427% |
| Sagittarius Life Science Corp | -55.03 Million TWD | -67.354% |
| NeoCore Technology Co., Ltd. | -64.64 Million TWD | -42.486% |
| TaiMed Biologics Inc. | -194.81 Million TWD | 52.718% |
| GlycoNex Incorporation | -178.36 Million TWD | 48.358% |
| VBI | -6.6 Million TWD | -1295.395% |
| GeneReach Biotechnology Corp. | -166.27 Million TWD | 44.602% |
| Taiwan Advance Bio-Pharmaceutical Inc. | -10.68 Million TWD | -762.292% |
| Visgeneer Inc. | -19.58 Million TWD | -370.213% |
| Mycenax Biotech Inc. | -682.84 Million TWD | 86.511% |
| Sunmax Biotechnology Co., Ltd. | 625.7 Million TWD | 114.721% |
| G&E Herbal Biotechnology Co., Ltd. | 72.4 Million TWD | 227.224% |
| Medigen Vaccine Biologics Corporation | -1.15 Billion TWD | 92.058% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -6.04 Million TWD | -1423.235% |
| Enimmune corporation | -223.74 Million TWD | 58.832% |
| TaiRx, Inc. | -212.29 Million TWD | 56.612% |
| CHO Pharma, Inc. | -306.08 Million TWD | 69.907% |
| EirGenix Inc. | -915.2 Million TWD | 89.936% |
| BioLASCO Taiwan Co., Ltd. | 49.74 Million TWD | 285.172% |
| Sunny Pharmtech Inc. | -63.32 Million TWD | -45.467% |
| Lin BioScience, Inc. | -687.19 Million TWD | 86.596% |
| BioGend Therapeutics Co., Ltd. | -156.32 Million TWD | 41.078% |
| Feng Chi Biotech Corp. | 22.79 Million TWD | 504.133% |
| Bio Preventive Medicine Corp. | -73.28 Million TWD | -25.687% |
| Lukas Biomedical Inc. | -47.35 Million TWD | -94.518% |
| RBC Bioscience Corporation | 6.43 Million TWD | 1532.504% |
| BiOptic Inc. | 37.74 Million TWD | 344.019% |
| BRIM Biotechnology, Inc. | -688.02 Million TWD | 86.612% |
| Shine-On BioMedical Co.,Ltd. | -37.16 Million TWD | -147.841% |
| Great Novel Therapeutics Biotech & Medicals | -61.54 Million TWD | -49.675% |
| Syngen Biotech Co.,Ltd. | 274.82 Million TWD | 133.516% |
| Anti-Microbial Savior BioteQ Co., Ltd | -51.78 Million TWD | -77.88% |
| SynCore Biotechnology Co.,Ltd | -38.17 Million TWD | -141.303% |
| Genomics BioSci & Tech. Co.,Ltd. | -168.06 Million TWD | 45.194% |
| Neith Corporation | -40.03 Million TWD | -130.085% |
| NaviFUS Corp. | -65.72 Million TWD | -40.136% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -88.08 Million TWD | -4.565% |
| Sinew Pharma Inc. | -170.92 Million TWD | 46.11% |
| Andros Pharmaceuticals Co.,Ltd | -68.15 Million TWD | -35.14% |
| Greenyn Biotechnology Co., Ltd | 130.66 Million TWD | 170.494% |
| Lumosa Therapeutics Co., Ltd. | -238.04 Million TWD | 61.305% |
| AP Biosciences Inc | -339.29 Million TWD | 72.853% |
| Medigen Biotechnology Corp. | -561.29 Million TWD | 83.59% |
| 3D Global Biotech Inc. | -57.95 Million TWD | -58.945% |
| Pharmosa Biopharm Inc. | 8.45 Million TWD | 1189.286% |
| Intech Biopharm Corporation | -337.98 Million TWD | 72.747% |
| Oneness Biotech Co., Ltd. | -1.31 Billion TWD | 92.984% |
| Eusol Biotech Co.,Ltd. | -51.61 Million TWD | -78.463% |
| TWi Biotechnology, Inc. | -170.68 Million TWD | 46.034% |
| Ever Supreme Bio Technology Co., Ltd | 539.39 Million TWD | 117.076% |
| TCI GENE Inc. | 11.67 Million TWD | 889.086% |
| MegaPro Biomedical Co., Ltd | -127.54 Million TWD | 27.784% |
| Senhwa Biosciences, Inc. | -296.3 Million TWD | 68.914% |
| Taiwan Bio Therapeutics Co., Ltd | -217.51 Million TWD | 57.653% |
| NatureWise Biotech & Medicals Corporation | 10.12 Million TWD | 1010.178% |
| PharmaEngine, Inc. | 274.65 Million TWD | 133.537% |
| Savior Lifetec Corporation | 30.03 Million TWD | 406.727% |
| TaiGen Biopharmaceuticals Holdings Limited | 136.73 Million TWD | 167.366% |
| OBI Pharma, Inc. | -1.04 Billion TWD | 91.198% |
| Meribank Biotech Co., Ltd | -125.34 Million TWD | 26.515% |
| Acepodia, Inc. | -817.31 Million TWD | 88.73% |
| Caliway Biopharmaceuticals Co., Ltd. | -488.45 Million TWD | 81.143% |